Page last updated: 2024-08-17

levodopa and Arteriosclerosis

levodopa has been researched along with Arteriosclerosis in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (66.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Müller, T	1
Lang, AE; Postuma, RB	1
Mosina, IV; Ryzhenkov, VE	1
Kaumeier, S	1
Duvoisin, RC	1
Kadykov, AS	1

Reviews

2 review(s) available for levodopa and Arteriosclerosis

Article	Year
Motor complications, levodopa metabolism and progression of Parkinson's disease. Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:7 Topics: Animals; Arteriosclerosis; Catechol O-Methyltransferase; Disease Progression; Dopamine; Dyskinesias; Enzyme Inhibitors; Free Radicals; Homocysteine; Humans; Levodopa; Nerve Degeneration; Parkinson Disease; Synaptic Transmission	2011
Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy? Neurology, 2004, Sep-14, Volume: 63, Issue:5 Topics: Antiparkinson Agents; Arteriosclerosis; Catechol O-Methyltransferase; Dementia; Disease Progression; Disease Susceptibility; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Levodopa; Models, Biological; Multicenter Studies as Topic; Oxidative Stress; Parkinson Disease; Randomized Controlled Trials as Topic; Substantia Nigra	2004

Article

Year

Motor complications, levodopa metabolism and progression of Parkinson's disease.

Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:7

Topics: Animals; Arteriosclerosis; Catechol O-Methyltransferase; Disease Progression; Dopamine; Dyskinesias; Enzyme Inhibitors; Free Radicals; Homocysteine; Humans; Levodopa; Nerve Degeneration; Parkinson Disease; Synaptic Transmission

2011

Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?

Neurology, 2004, Sep-14, Volume: 63, Issue:5

Topics: Antiparkinson Agents; Arteriosclerosis; Catechol O-Methyltransferase; Dementia; Disease Progression; Disease Susceptibility; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Levodopa; Models, Biological; Multicenter Studies as Topic; Oxidative Stress; Parkinson Disease; Randomized Controlled Trials as Topic; Substantia Nigra

2004

Other Studies

4 other study(ies) available for levodopa and Arteriosclerosis

Article	Year
[Effect of L-DOPA on the development of experimental hyperlipidemia and atherosclerosis]. Biulleten' eksperimental'noi biologii i meditsiny, 1981, Volume: 91, Issue:3 Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Guinea Pigs; Hyperlipidemias; Hypolipidemic Agents; Levodopa; Liver; Male; Rabbits; Rats; Triglycerides	1981
[Parkinsonism]. Fortschritte der Medizin, 1978, Jul-27, Volume: 96, Issue:28 Topics: Amantadine; Arteriosclerosis; Genes, Dominant; Guam; Histamine H1 Antagonists; Humans; Levodopa; Middle Aged; Parasympatholytics; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Physical Therapy Modalities; Speech Disorders	1978
Problems in the treatment of Parkinsonism. Advances in experimental medicine and biology, 1977, Volume: 90 Topics: Antiparkinson Agents; Arteriosclerosis; Carbidopa; Diagnosis, Differential; Drug Combinations; Eye Manifestations; Humans; Levodopa; Mental Disorders; Movement Disorders; Parasympatholytics; Paresthesia; Parkinson Disease; Vision Disorders	1977
[The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1976, Volume: 76, Issue:2 Topics: Amantadine; Arteriosclerosis; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary	1976